{
    "clinical_study": {
        "@rank": "45135", 
        "arm_group": [
            {
                "arm_group_label": "Rotigotine in Healthy Japanese", 
                "arm_group_type": "Experimental", 
                "description": "Rotigotine transdermal patch\nSingle dose application of 2 mg / 24 hours Rotigotine in Healthy Japanese subjects\nTransdermal patch over 24 hours"
            }, 
            {
                "arm_group_label": "Rotigotine in Caucasian", 
                "arm_group_type": "Experimental", 
                "description": "Rotigotine transdermal patch\nSingle-Dose application of 2 mg / 24 hours Rotigotine in healthy Caucasian subjects\nTransdermal patch over 24 hours"
            }
        ], 
        "brief_summary": {
            "textblock": "To investigate the Pharmacokinetics (PK) of transdermally delivered Rotigotine in Japanese\n      and Caucasian Female and Male Healthy Subjects."
        }, 
        "brief_title": "Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects", 
        "completion_date": {
            "#text": "December 2002", 
            "@type": "Actual"
        }, 
        "condition": "Healthy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject is healthy according to assessments done at eligibility assessment (medical\n             history, physical examination, blood pressure, heart rate, Electrocardiogram (ECG),\n             hematology, clinical chemistry, urinalysis)\n\n          -  Subject is of normal body-weight as determined by a body mass index ranging between\n             18 to 28 kg / m\u00b2\n\n          -  Subject is Japanese or Caucasian. Japanese subjects are born in Japan and left Japan\n             not more than 10 years ago. Both parents of the Japanese subjects are 100 % Japanese\n\n        Exclusion Criteria:\n\n          -  Subjects (females) without medically adequate contraception (e.g. mechanical\n             contraception (Intrauterine-Device IUD), sterilization, hysterectomy) or on lactation\n             or pregnant women. Subjects with oral contraception or hormone replacement within 4\n             weeks prior to eligibility assessment\n\n          -  Subject has a history of chronic alcohol or drug abuse\n\n          -  Subject has a consumption of more than 20 g of alcohol / day (amount corresponds to\n             0.5 l of beer / day or 0.25 l of wine / day or 3 glasses (\u00e0 2 cl) of liquor / day\n\n          -  Subject has a clinically relevant allergy\n\n          -  Subject has a known or suspected drug hypersensitivity in particular, to any\n             component of the trial medication\n\n          -  Subject has any clinically significant abnormality in physical examination\n\n          -  Subject has a heart rate at rest less than 50  beats per minute (bpm) or more than\n             100 bpm\n\n          -  Subject has systolic blood pressure lower than 100 mmHg or higher than 145 mmHg or\n             diastolic blood pressure higher than 95 mmHg or lower than 60 mmHg\n\n          -  Subject has an atopic or eczematous dermatitis and / or an active skin disease or\n             skin tumors\n\n          -  Subject has a history of significant skin hypersensitivity to adhesives or other\n             transdermal products or recent unresolved contact dermatitis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01761526", 
            "org_study_id": "SP717"
        }, 
        "intervention": {
            "arm_group_label": [
                "Rotigotine in Healthy Japanese", 
                "Rotigotine in Caucasian"
            ], 
            "description": "Rotigotine transdermal patch, single-dose application over 24 hours 2 mg /24 hours (10 cm2)", 
            "intervention_name": "Rotigotine transdermal patch", 
            "intervention_type": "Drug", 
            "other_name": "Neupro"
        }, 
        "intervention_browse": {
            "mesh_term": "N 0437"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Rotigotine", 
            "Neupro", 
            "Japanese", 
            "Caucasian", 
            "Male", 
            "Female", 
            "Single dose", 
            "Pharmacokinetics"
        ], 
        "lastchanged_date": "January 3, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Neuss", 
                    "country": "Germany"
                }, 
                "name": "01"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "Parallel Group Trial to Evaluate the Pharmacokinetics and Safety / Tolerability of Single-Dose Treatment With Rotigotine Continuous Delivery System (10 cm2 / 4.5 mg) in Japanese and Caucasian Healthy Subjects", 
        "overall_official": {
            "affiliation": "+1 877 822 9493 (UCB)", 
            "last_name": "UCB Clinical Trial Call Center", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "October 2002", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Area under the concentration-time curve (AUC) from zero up to the last measured concentration greater than the Lower Limit of Quantitation (LOQ) [AUC (0-t)] of unconjugated Rotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Area under the concentration-time curve from zero up to the last measured concentration greater than the Lower Limit of Quantitation (LOQ) normalized  [AUC (0-t)norm] of unconjugated Rotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Maximum concentration in plasma [Cmax] of unconjugated Rotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Maximum concentration in plasma normalized by body weight [Cmax,norm] of unconjugated Rotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Area under the concentration-time curve from zero up to the last measured concentration greater than the Lower Limit of Quantitation (LOQ) [AUC (0-t)] of total Rotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Maximum concentration in plasma [Cmax] of total Rotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Maximum concentration in plasma normalized by body weight [Cmax,norm] of total Rotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Area under the concentration-time curve from zero up to the last measured concentration greater than the Lower Limit of Quantitation (LOQ) [AUC (0-t)] of total Despropylrotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Area under the concentration-time curve from zero up to the last measured concentration greater than the Lower Limit of Quantitation (LOQ) normalized by body weight [AUC (0-t)] of total Despropylrotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Maximum concentration in plasma [Cmax] of total Despropylrotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Maximum concentration in plasma normalized by body weight [Cmax,norm] of total Despropylrotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Area under the concentration-time curve from zero up to the last measured concentration greater than the Lower Limit of Quantitation (LOQ) [AUC (0-t)] of total Desthienylethylrotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Area under the concentration-time curve from zero up to the last measured concentration greater than the Lower Limit of Quantitation (LOQ) normalized by body weight [AUC (0-t)] of total Desthienylethylrotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Maximum concentration in plasma [Cmax] of total Desthienylethylrotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Maximum concentration in plasma normalized by body weight [Cmax, norm] of total Desthienylethylrotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01761526"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Terminal half-life [t1/2] of unconjugated Rotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Time of maximum concentration [tmax] of unconjugated Rotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Area under the concentration-time curve from zero to infinity [AUC (0-inf)] of unconjugated Rotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Total body clearance (CL) of unconjugated Rotigotine normalized by body weight  (BW) [CL/f/BW]", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Apparent volume of distribution of unconjugated Rotigotine normalized by body weight [Vz/f/BW]", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Amounts of unconjugated Rotigotine excreted in urine [Ae]", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Fraction of unconjugated Rotigotine excreted into urine [fe (%  of dose)]", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Renal Clearance [CLR] of unconjugated Rotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Terminal half-life [t1/2] of total Rotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Time of maximum concentration [tmax] of total Rotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Area under the concentration-time curve from zero to infinity [AUC (0-inf)] of total Rotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Total body clearance of total Rotigotine normalized by body weight [CL/f/BW]", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Apparent volume of distribution normalized of total Rotigotine by body weight [Vz/f/BW]", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Amount of total Rotigotine excreted into urine [Ae]", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Fraction of total Rotigotine excreted into urine [fe (% of dose)]", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Renal clearance [CLR] of total Rotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Terminal half-life [t1/2] of total Despropylrotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Time of maximum concentration [tmax] of total Despropylrotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Area under the concentration-time curve from zero to infinity [AUC (0-inf)] of total Despropylrotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Total body clearance of total Despropylrotigotine normalized by body weight [CL/f/BW]", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Apparent volume of distribution of total Despropylrotigotine normalized by body weight [Vz/f/BW]", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Amount of total Despropylrotigotine excreted into urine [Ae]", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Fraction of total Despropylrotigotine excreted into urine [fe (% of dose)]", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Renal Clearance [CLR] of total Despropylrotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Terminal half-life [t1/2] of total Desthienylethylrotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Time of maximum concentration [tmax] of total Desthienylethylrotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Area under the concentration-time curve from zero to infinity [AUC (0-inf)] of total Desthienylethylrotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Total body clearance of total Desthienylethylrotigotine normalized by body weight [CL/f/BW]", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Apparent volume of distribution of total Desthienylethylrotigotine normalized by body weight [Vz/f/BW]", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Amount of total Desthienylethylrotigotine excreted into urine [Ae]", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Fraction of total Desthienylethylrotigotine excreted into urine  [fe (%of dose)]", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }, 
            {
                "description": "Blood sampling at 0 hours (Pre-Dose), 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 24 hours, 25 hours, 26 hours, 28 hours, 30 hours, 33 hours, 36 hours, 48 hours, and 60 hours Post-Dose", 
                "measure": "Renal clearance [CLR] of total Desthienylethylrotigotine", 
                "safety_issue": "No", 
                "time_frame": "From Baseline (0 hours Pre-Dose) up to 60 hours Post-Dose"
            }
        ], 
        "source": "UCB, Inc.", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Schwarz BioSciences GmbH", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Alfred-Nobel-Str. 10", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "40789 Monheim am Rhein", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "UCB BIOSCIENCES GmbH", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2002", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}